CAS No. |
2058080-25-2 |
中文名称 |
二甲基((2S,2'S)-((2S,2'S)-(((S)-6-(色烷-7-基)-1-氟-6H-苯并[5,6][1,3]噁嗪并[3,4-a]吲哚-3,10-二亚基)双(1H-咪唑-5,2-二亚基))双(吡咯烷-2,1-二亚基))双(3-甲基-1-氧代丁烷-1,2-二亚基))二氨基甲酸酯 |
英文名称 |
Dimethyl ((2S,2'S)-((2S,2'S)-(((S)-6-(chroman-7-yl)-1-fluoro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate |
别名 |
HCV-IN-4;Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[(6S)-6-(3,4-dihydro-2H-1-benzopyran-7-yl)-1-fluoro-10-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-3-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl est... |
标准英文名 |
dimethyl ((2S,2'S)-((2S,2'S)-(((S)-6-(chroman-7-yl)-1-fluoro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate |
分子式 |
C52H58FN9O8 |
分子量 |
956.09
|
精确分子量 |
955.44
|
SMILES |
FC1=C2C3=CC4=CC(C5=CN=C(N5)[C@@]6(CCCN6C([C@@H](NC(OC)=O)C(C)C)=O)[H])=CC=C4N3[C@]([H])(C7=CC=C8CCCOC8=C7)OC2=CC(C9=CN=C(N9)[C@@]%10(CCCN%10C([C@@H](NC(OC)=O)C(C)C)=O)[H])=C1 |
标准SMILES |
CC(C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1C1NC(=CN=1)C1C=C2O[C@@H](C3=CC=C4CCCOC4=C3)N3C(=CC4=CC(=CC=C34)C3=CN=C(N3)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)OC)C(C)C)C2=C(F)C=1 |
用途 |
HCV-IN-4 is a potent, orally available HCV NS5A inhibitor that suppresses the replication of GT1a, GT2b, GT3a, GT1a Y93H, and GT1a L31V, with EC90 values of 3 pM, 0.3 nM, 0.01 nM, 0.5 nM, and 0.02 nM, respectively. |
InChIKey |
XELUICQHKUXLAP-YTBPSGRCSA-N |